Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Overview
Learn About Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a rare condition that prevents the body from converting certain fats to energy, particularly during periods without food (fasting).
Variants (also known as mutations) in the HADHA gene cause LCHAD deficiency. The HADHA gene provides instructions for making part of an enzyme complex called mitochondrial trifunctional protein. This enzyme complex functions in mitochondria, the energy-producing centers within cells. As the name suggests, mitochondrial trifunctional protein contains three enzymes that each perform a different function. This enzyme complex is required to break down (metabolize) a group of fats called long-chain fatty acids. Long-chain fatty acids are found in foods such as milk and certain oils. These fatty acids are stored in the body's fat tissues. Fatty acids are a major source of energy for the heart and muscles. During periods of fasting, fatty acids are also an important energy source for the liver and other tissues.
The incidence of LCHAD deficiency is unknown. One estimate, based on a Finnish population, indicates that 1 in 62,000 pregnancies is affected by this disorder. In the United States, the incidence is probably much lower.
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have variants. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.
State University Of Iowa
Erin Boese is an Ophthalmologist in Iowa City, Iowa. Dr. Boese is rated as an Experienced provider by MediFind in the treatment of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy. Dr. Boese is currently accepting new patients.
University Professional Services
Cary Harding is a Medical Genetics specialist and a Pediatrics provider in Portland, Oregon. Dr. Harding is rated as a Distinguished provider by MediFind in the treatment of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. His top areas of expertise are Phenylketonuria (PKU), Urea Cycle Disorders (UCD), Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Mitochondrial Trifunctional Protein Deficiency, and Hepatectomy. Dr. Harding is currently accepting new patients.
Charlotte Haglind practices in Stockholm, Sweden. Ms. Haglind is rated as a Distinguished expert by MediFind in the treatment of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. Her top areas of expertise are Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Mitochondrial Trifunctional Protein Deficiency, Primary Carnitine Deficiency, and Rhabdomyolysis.
Published Date: January 20, 2023
Published By: National Institutes of Health